Acadia Healthcare (NASDAQ:ACHC) Hits New 52-Week Low – Here’s What Happened

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price hit a new 52-week low on Tuesday . The stock traded as low as $25.12 and last traded at $25.15, with a volume of 756654 shares changing hands. The stock had previously closed at $26.39.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on ACHC shares. Mizuho reduced their target price on Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research note on Tuesday, March 25th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. KeyCorp lowered their price objective on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, March 3rd. TD Cowen decreased their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Finally, Bank of America decreased their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $50.39.

Acadia Healthcare Trading Up 0.3 %

The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a 50-day moving average price of $32.13 and a 200-day moving average price of $40.46. The company has a market capitalization of $2.20 billion, a price-to-earnings ratio of 7.84, a PEG ratio of 1.46 and a beta of 1.13.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. FMR LLC increased its position in shares of Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company’s stock worth $247,045,000 after acquiring an additional 4,489,681 shares in the last quarter. Madison Avenue Partners LP purchased a new position in shares of Acadia Healthcare during the fourth quarter valued at $76,339,000. Sachem Head Capital Management LP purchased a new stake in Acadia Healthcare in the 4th quarter worth about $52,734,000. Khrom Capital Management LLC purchased a new position in Acadia Healthcare during the 4th quarter valued at about $49,602,000. Finally, Balyasny Asset Management L.P. purchased a new stake in shares of Acadia Healthcare in the fourth quarter worth approximately $43,092,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.